- Home
- SUPN vs APLD Comparison
SUPN vs APLD Comparison
Compare SUPN & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- APLD
- Stock Information
- Founded
- SUPN 2005
- APLD 2001
- Country
- SUPN United States
- APLD United States
- Employees
- SUPN N/A
- APLD N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- APLD Investment Bankers/Brokers/Service
- Sector
- SUPN Health Care
- APLD Finance
- Exchange
- SUPN Nasdaq
- APLD Nasdaq
- Market Cap
- SUPN 2.6B
- APLD 3.7B
- IPO Year
- SUPN 2012
- APLD N/A
- Fundamental
- Price
- SUPN $44.80
- APLD $19.83
- Analyst Decision
- SUPN Buy
- APLD Strong Buy
- Analyst Count
- SUPN 2
- APLD 11
- Target Price
- SUPN $43.00
- APLD $14.73
- AVG Volume (30 Days)
- SUPN 654.2K
- APLD 25.9M
- Earning Date
- SUPN 11-03-2025
- APLD 10-08-2025
- Dividend Yield
- SUPN N/A
- APLD N/A
- EPS Growth
- SUPN 1411.53
- APLD N/A
- EPS
- SUPN 1.14
- APLD N/A
- Revenue
- SUPN $665,125,000.00
- APLD $144,193,000.00
- Revenue This Year
- SUPN $4.84
- APLD $85.51
- Revenue Next Year
- SUPN $17.69
- APLD $84.83
- P/E Ratio
- SUPN $38.93
- APLD N/A
- Revenue Growth
- SUPN 5.55
- APLD 5.54
- 52 Week Low
- SUPN $29.16
- APLD $3.31
- 52 Week High
- SUPN $46.79
- APLD $19.99
- Technical
- Relative Strength Index (RSI)
- SUPN 58.16
- APLD 74.60
- Support Level
- SUPN $43.44
- APLD $18.65
- Resistance Level
- SUPN $46.72
- APLD $19.96
- Average True Range (ATR)
- SUPN 1.08
- APLD 1.21
- MACD
- SUPN -0.48
- APLD 0.37
- Stochastic Oscillator
- SUPN 40.60
- APLD 95.42
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.